Literature DB >> 21518936

The impact of new cardiovascular device technology on health care costs.

Peter W Groeneveld, Daniel Polsky, Feifei Yang, Lin Yang, Andrew J Epstein.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21518936      PMCID： PMC3164860          DOI： 10.1001/archinternmed.2011.141

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  7 in total

1.  Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest.

Authors:  Peter W Groeneveld; Paul A Heidenreich; Alan M Garber
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

Review 2.  Medical care costs: how much welfare loss?

Authors:  J P Newhouse
Journal:  J Econ Perspect       Date:  1992

3.  2006 National Hospital Discharge Survey.

Authors:  Carol J DeFrances; Christine A Lucas; Verita C Buie; Aleksandr Golosinskiy
Journal:  Natl Health Stat Report       Date:  2008-07-30

4.  Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.

Authors:  Demosthenes G Katritsis; John P A Ioannidis
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

5.  Diffusion of laparoscopic cholecystectomy among general surgeons in the United States.

Authors:  J J Escarce; B S Bloom; A L Hillman; J A Shea; J S Schwartz
Journal:  Med Care       Date:  1995-03       Impact factor: 2.983

6.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

7.  Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.

Authors:  David J Cohen; Ameet Bakhai; Chunxue Shi; Louise Githiora; Tara Lavelle; Ronna H Berezin; Martin B Leon; Jeffrey W Moses; Joseph P Carrozza; James P Zidar; Richard E Kuntz
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690
  7 in total
  4 in total

1.  Variations in the use of an innovative technology by payer: the case of drug-eluting stents.

Authors:  Andrew J Epstein; Jonathan D Ketcham; Saif S Rathore; Peter W Groeneveld
Journal:  Med Care       Date:  2012-01       Impact factor: 2.983

Review 2.  Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention.

Authors:  Neil J Wimmer; Robert W Yeh
Journal:  Trends Cardiovasc Med       Date:  2012-07-28       Impact factor: 6.677

3.  Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Authors:  Connie N Hess; Sunil V Rao; David Dai; Megan L Neely; Robert N Piana; John C Messenger; Eric D Peterson
Journal:  Am Heart J       Date:  2014-01-04       Impact factor: 4.749

Review 4.  Preoperative management of antiplatelet drugs for a coronary artery stent: how can we hit a moving target?

Authors:  Thomas R Vetter; James M Hunter; Arthur M Boudreaux
Journal:  BMC Anesthesiol       Date:  2014-08-23       Impact factor: 2.217
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.